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Abstract
Background: The aim of this paper is to assess the current state of quality and outcomes measures
being reported for hepatic resections in the recent literature.
Methods: Medline and PubMed databases were searched for English language articles published
between 1 January 2002 and 30 April 2013. Two examiners reviewed each article and relevant cita-
tions for appropriateness of inclusion, which excluded papers of liver donor hepatic resections,
repeat hepatectomies or meta-analyses. Data were extracted and summarized by two examiners for
analysis.
Results: Fifty-five studies were identified with suitable reporting to assess peri-operative mortality in
hepatic resections. In only 35% (19/55) of the studies was the follow-up time explicitly stated, and
in 47% (26/55) of studies peri-operative mortality was limited to in-hospital or 30 days. The time period
in which complications were captured was not explicitly stated in 19 out of 28 studies. The remaining
studies only captured complications within 30 days of the index operation (8/28). There was a paucity
of quality literature addressing truly patient-centred outcomes.
Conclusion: Quality outcomes after a hepatic resection are inconsistently reported in the literature.
Quality outcome studies for a hepatectomy should report mortality and morbidity at a minimum of
90 days after surgery.
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Introduction
A hepatic resection has evolved into a common surgical proce-
dure for a wide range of benign and malignant indications.
The number of hepatic resections performed in the United
States has been increasing over time.1 Decreasing mortality
rates for major hepatic resections have been reported over
time.1,2 Despite the complexity of resections and the comor-
bidities of patients increasing, reported morbidity rates have
remained relatively stable over time.2–4 While experience with
complex hepatic resections has grown with favourable
outcomes, more data are needed to risk stratify patients and
identify those at a high and low risk of post-operative compli-
cations in order to provide accurate and informed pre-opera-
tive counselling.
Patient-centred outcomes that look beyond short-term
mortality and disease-free survival should be part of quality
outcomes in a hepatic resection. Quality outcomes after a
hepatic resection are inconsistently defined and variably
reported in the literature. Benchmarks are being made based
on outcomes data from a wide variety of sources, ranging from
single institution centres to national administrative databases.
The aim of this research was to review the most current decade
of published outcomes after a hepatic resection, to identify and
define robust quality and outcome parameters, and to propose
a set of criteria for liver resection outcomes research in the
future.
This study was presented at the Annual Meeting of the AHPBA, 19-23
February 2014, Miami, Florida.
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Method
This systematic review was conducted in accordance with the
PRISMA guidelines.5 An electronic search of Medline and
PubMed databases was performed using combinations of the
keywords ‘quality outcomes,’ ‘hepatectomy,’ ‘liver resection’
and ‘hepatic resection.’ The search was limited to studies
published between 1 January 2002 and 30 April 2013. Inclusion
criteria included studies focusing on resection for neoplastic
disease with curative intent, although studies that integrated
non-neoplastic or trauma indications along with malignant
indications were reviewed. Exclusion criteria included non-
English language publications, meta-analyses and series limited
to living donor hepatectomies and repeat hepatectomies.
Two examiners reviewed all abstracts of studies identified
for potential inclusion. Additional potential studies for inclu-
sion were identified from the references of studies identified in
the database search. Reviewers then compiled study character-
istics and outcomes of interest, including study type (single
centre, multi-institutional or administrative database), disease
type, reported follow-up, extent of hepatic resection (major
hepatectomy defined as ≥ 3 segments) and the time period
of data collection. Outcomes of interest included mortality,
morbidity, major morbidity and post-operative liver failure;
the various definitions of these outcomes were also recorded.
Complications were considered defined if the explicit type of
complications were reported and were considered graded if
they were defined and ranked on an ordinal scale. Studies were
then compared along the lines of reported mortality and
morbidity outcomes.
Results
The results of the review process are reported in the Fig. 1.
Reviewers identified 55 studies with suitable reporting to assess
peri-operative mortality, and 28 studies with adequate report-
ing of peri-operative morbidity. The 55 studies reporting peri-
operative mortality were heterogeneous in study population,
design and outcome reporting. A meta-analysis of these reports
with any meaningful statistical validity was not possible owing
to heterogeneity. Study design and mortality measures are
summarized in Table 1. Ranges of reported mortality rates
were as follows: 0–11.9% (30 day), 3.4–9.1% (60 day, and
0.9–10.8% (90 day). Study characteristics of the 28 studies
reporting peri-operative morbidity after hepatic resection are
Figure 1 Flow diagram illustrating the selection of studies in the review process
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summarized in Table 2. Significant heterogeneity in study design
precluded any meaningful meta-analysis of the published find-
ings, especially with regard to the definition of post-operative
liver insufficiency. The most commonly reported definition of
post-operative liver insufficiency is a post-operative peak total
bilirubin > 7 mg/dl (Table 3).
There was a paucity of studies addressing patient-centred
outcomes beyond peri-operative mortality and classic surgical
complications. Few studies focused specifically on length of
stay and readmission rates in exclusive hepatic resection popu-
lations. Length of stay appears to be decreasing over time after
a hepatic resection.1,6 In two studies that examined risk factors
for readmission after complex surgery, including hepatic resec-
tions, pre-operative sepsis, American Society of Anesthesiolo-
gists class, the presence of an open wound, post-operative
complications, increased age, decreased oral intake and an
increased number of discharge medications, were all associated
with an increased risk of readmission.7,8 Several studies were
identified that addressed survey-based quality of life outcomes
after hepatic resection.9–14 After hepatic resection, patient-
reported quality of life indicators appear to return to baseline
or improve on the order of 3–6 months after operation, with
some reporting delays in return to baseline approaching
12 months.9,11,12,14 Questionnaires have been developed and
validated that are specific to patient-reported outcomes after
hepatic resections.15,16
Discussion
The findings in this study reveal a great deal of heterogeneity
of quality outcomes and reporting parameters for studies
describing patients undergoing a hepatic resection. Even the
seemingly straightforward measure of peri-operative mortality
is reported over a wide range of time (i.e. 30, 60 or 90 days)
that limits the ability to compare risk factors and interventions
across studies. Morbidities are also reported over a range of
post-operative times and are inconsistently defined and graded.
Follow-up is often not explicitly stated in reports. Finally,
patient- and oncological-centred outcomes are not widely
reported, thus the definition of ‘quality’ outcomes after a hepa-
tic resection is difficult to capture by reviewing the literature.
Traditional 30-day mortality is no longer considered an
appropriate length of time to capture the true mortality related
to an operative hepatic resection. A significant number of
deaths related to liver failure and other complications from
surgery occur after the traditional 30-day post-operative
Table 1 Summary of hepatic resection study design parameters
reporting peri-operative mortality outcomes1–4,6,8–11,19–25,27,31,37–73
Data Source
Large Administrative Database 26/55 (47%)
Multi-centre 5/55 (9%)
Single-centre 24/55 (44%)
Follow-Up Time Reported 19/55 (35%)
Time Period for Mortality
Strictly In-hospital 11/55 (20%)
30 day 15/55 (27%)
60 day 2/55 (4%)
90 day 17/55 (31%)
Not Defined 10/55 (18%)
Table 2 Summary of hepatic resection study design parameters
reporting peri-operative morbidity outcomes2–4,10,11,19,22,23,25,27,38,
41–43,45-48,51,52,54,55,58,62,63,69,71,73
Data Source
Large Administrative Database 10/28
Multi-centre 2/28
Single-centre 16/28
Diseases Reported
Both Benign and Malignant Diseases 19/28
Hepatocellular Carcinoma Only 5/28
Colorectal Liver Metastases Only 4/28
Follow-Up Time Reported 14/28
Time Period For Morbidity
30 day 8/28
90 day 1/28
Not Defined 19/28
Complication Classification
Not graded, but clearly defined 17/28
Graded (Clavien–Dindo type)28 7/28
Neither graded nor defined 4/28
Independent Assessment of Complications 10/28
Table 3 Summary of hepatic resection study design parameters
reporting post-operative liver insufficiency2,4,11,19,22,25,38,40,47,60,
62,72,73
Data Source
Large Administrative Database 0/13
Multi-centre 2/13
Single-centre 11/13
Disease
Benign and Malignant 8/13
HCC Only 2/13
CRLM Only 3/13
Liver Insufficiency Definition
’50-50 Criteria’37 2/13
Peak Total bilirubin > 7 mg/dl 6/13
Other 5/13
HCC, hepatocellular carcinoma; CRLM, colorectal liver metastases.
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period.17–20 The magnitude of this effect is sizable and consis-
tent across multiple indications for hepatic resection, including
hepatocellular carcinoma and colorectal liver metastases
(CRLM), with most studies reporting an approximate doubling
of mortality rates from 30 to 90 days post-operatively.19–21
Whether this increase in mortality is simply a function of a
larger time frame in which to capture events or an accurate
reflection of true surgery-associated mortality is a question that
can only be answered with further well-designed studies.
While there is less evidence that peri-operative morbidity
rates would likewise increase from 30 to 90 days post-opera-
tively, it is certainly logical to assume that there are a signifi-
cant number of complications that are under reported by
traditional 30-day studies. A lack of follow-up beyond 30 days
is the critical shortcoming of the use of large administrative
databases to capture and report quality outcomes after hepatic
surgery. This inherent limitation will limit the use of such large
databases to draw meaningful conclusions regarding risk fac-
tors for poor peri-operative outcomes, unless databases are
integrated and analysed as such to allow reporting of 90-day
outcomes. Until then, collaborative efforts between multiple
high volume centres will be the best opportunity to perform
appropriate assessment of risk factors for poor quality
outcomes in hepatic surgery. Based on the mounting recent
evidence, it is clear that peri-operative mortality and morbidity
after a hepatic resection should be reported within the 90-day
operative period.
Peri-operative morbidity is substantial after major hepatic
resections. Morbidity rates (reported from 30 to 90 days post-
operatively) range from 14% to 55%.2,3,22–27 Complications are
much more difficult to define and compare across different
studies from different institutions. The commonly used
Clavien–Dindo classification of post-operative complications is
a validated measure of the severity of post-operative complica-
tions with a wide range of applications across surgical special-
ties.28 While this classification is easily assessed and reportable,
most of the studies reviewed did not classify complications in
a graded fashion; only 25% of studies reviewed used the
Clavien–Dindo classification system. Independent assessment
of peri-operative complications is preferred compared with
provider assessment to reduce potential bias in under-reporting
of complications. Post-operative liver insufficiency is another
potential measure of quality outcomes after a hepatic resection.
The definition of post-operative liver insufficiency is variable
(Table 3). The most common measure reported in this review,
defined as a post-operative peak in total bilirubin > 7 mg/dl, is
a reliable, objective and easily measured parameter that is the
preferred measurement to use when reporting outcomes after
hepatic resection. A peak postoperative total bilirubin > 7 mg/dl
is associated with increased morbidity and mortality.19 Rahbari
et al.29 have summarized the relevant literature regarding
assessment of post-hepatectomy liver failure in an effort to
reach a consensus definition. The definition proposed in the
consensus statement focuses on the assessment of the impact
of clinical management and an assessment of synthetic func-
tion by abnormal laboratory values. While this definition is
reasonably simple and easily applied, there remains some
degree in subjectivity regarding the assessment of the impact
on clinical management. Absolute total bilirubin is proposed as
an even more simplified measure of post-operative liver
dysfunction, as it is easily reproducible, routinely measured
and is objective. Post-operative hyperbilirubinaemia is also
associated with an increased risk of readmission after a major
hepatectomy, thus the routine reporting and assessment of
post-operative total bilirubin levels may provide more oppor-
tunities for quality and outcomes assessment.30
Novel patient-centred outcome measures are needed to assess
quality results after a hepatic resection that go beyond tradi-
tional measures of operative morbidity. In an age of increasing
scrutiny of health care resource utilization, readmission rates
are an important metric that may capture both surgeon and
system factors related to quality. More patients are being dis-
charged to places other than home after a hepatic resection.31
The rate of readmission within 90 days after A hepatic resection
may approach 15%.32 Recently, in a series of 266 general surgi-
cal oncology patients, risk factors for 90-day readmission
included age ≥ 69 years, ≥ 9 medications at discharge, poor
oral intake and discharge home with a home health agency.7
These risk factors and others need to be further evaluated in
larger series of exclusively hepatic resection patients to define
areas for improvement that may reduce readmission rates and
improve health care resource utilization. These types of granu-
lar, patient-specific factors are difficult to capture in large
administrative databases based on claims data, therefore, multi-
institutional series will have to lead the way in these efforts.
Peri-operative complications have been associated with
worse oncological outcomes after a hepatic resection for
CRLM.33 An uncomplicated post-operative course is critical
for the patient undergoing a hepatic resection for malignancy,
particularly when an up-front hepatic resection is being per-
formed without neoadjuvant therapy for CRLM. Complications
have been associated with a delay in initiation of post-opera-
tive chemotherapy, whereas lack of adjuvant therapy has been
shown to be an independent risk factor for worse survival after
a up-front hepatic resection.33,34 For these reasons, studies
reporting outcomes after hepatic resections for malignancies
should report the success rate of timely initiation of adjuvant
systemic chemotherapy, when oncologically appropriate, as a
global outcome measure that can capture undesirable irregular-
ities in a patient’s post-operative course.
A recent review reported similar findings to this study, again
emphasizing the heterogeneity of reporting of outcomes and
risk factors in hepatic resection publications.35 This report
highlights the lack of relevant patient-reported outcomes in the
literature and how poorly defined morbidity outcomes are in
current hepatic resection studies.
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Regarding quality of life instruments, the European Organi-
sation for Research and Treatment of Cancer Quality of Life
Questionnaire –C30 (EORTC –Q30) is a well-studied, validated
instrument that has been used to assess outcomes after liver
resection for colorectal metastases.11 The Short-Form-12
Health Survey and the Functional Assessment of Cancer Ther-
apy Hepatobiliary (FACT-Hep) has also been used to assess
outcomes after a liver resection.10,35 No one measure has been
shown to be superior to another. There are currently a wide
variety of validated instruments for researchers to use to assess
quality of life after a hepatic resection, although further study
is needed to assess the optimal instruments to use for
outcomes reporting.
The findings of this review need to be interpreted with the
study limitations in mind. Certainly, as described by Lim et al.36,
there is a high risk of bias in the publication and reporting of
results. The search strategy may have missed relevant articles,
and the limiting of the review to the most recent decade may
have omitted relevant, high-quality studies. There is certainly a
high degree of heterogeneity in the reporting of outcomes across
studies, which limits the feasibility of meta-analysis techniques
to summarize outcomes and relevant risk factors in a meaningful
way. Lim et al. made concerted efforts to summarize and
quantitatively estimate the effects of multiple risk factors on
outcomes in the literature.36 This work instead focused on a
more qualitative assessment of the current state of outcomes
reporting in hepatic resection literature. This assessment is the
rationale behind our proposed reporting criteria.
Based on the findings of the present study, a set of criteria
are proposed which future studies of quality outcomes after a
hepatic resection should try to achieve to improve the consis-
tency and quality of outcomes reporting in hepatic surgery:
1 Peri-operative mortality should be reported within the
90-day post-operative period
2 Peri-operative morbidity should be reported within the
90-day post-operative period
3 Peri-operative complications should be graded in a
standard fashion
4 Complications should be assessed by an independent
observer when possible
5 Post-operative liver insufficiency, when reported, should
be defined as a peak in post-operative total bilirubin
> 7 mg/dl
6 When oncologically appropriate, timely initiation of adju-
vant chemotherapy after hepatic resection for malignancy
should be reported
7 Patient-reported quality-of-life outcomes should be
assessed when possible by validated instruments
Currently, most of the studies in the literature reporting
outcomes after a hepatic resection do not meet these criteria
(Tables 1–3). These measures are proposed in an effort to raise
the quality of outcomes reporting and improve the compara-
bility of study findings across a variety of institutional settings.
Funding sources
None.
Conflict of interest
None declared.
References
1. Dimick JB, Wainess RM, Cowan JA, Upchurch GR Jr, Knol JA, Colletti
LM. (2004) National trends in the use and outcomes of hepatic resec-
tion. J Am Coll Surg 199:31–38.
2. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben Porat L, Little S
et al. (2002). Improvement in perioperative outcome after hepatic resec-
tion: analysis of 1,803 consecutive cases over the past decade. Ann
Surg 236:397–406; discussion-7.
3. Mayo SC, Heckman JE, Shore AD, Nathan H, Parikh AA, Bridges JF
et al. (2011) Shifting trends in liver-directed management of patients
with colorectal liver metastasis: a population-based analysis. Surgery
150:204–216.
4. Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA et al.
(2013) Greater complexity of liver surgery is not associated with an
increased incidence of liver-related complications except for bile leak:
an experience with 2,628 consecutive resections. J Gastrointest Surg
17:57–65.
5. Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA state-
ment. Int J Surg 8:336–341.
6. Schneider EB, Hyder O, Wolfgang CL, Hirose K, Choti MA, Makary MA
et al. (2012) Patient readmission and mortality after surgery for hepato-
pancreato-biliary malignancies. J Am Coll Surg 215:607–615.
7. Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A et al.
(2011) Readmission rates after abdominal surgery: the role of surgeon,
primary caregiver, home health, and subacute rehab. Ann Surg
254:591–597.
8. Kassin MT, Owen RM, Perez SD, Leeds I, Cox JC, Schnier K et al.
(2012) Risk factors for 30-day hospital readmission among general sur-
gery patients. J Am Coll Surg 215:322–330.
9. Martin RC, Eid S, Scoggins CR, McMasters KM. (2007) Health-related
quality of life: return to baseline after major and minor liver resection.
Surgery 142:676–684.
10. Bruns H, Kratschmer K, Hinz U, Brechtel A, Keller M, Buchler MW et al.
(2010) Quality of life after curative liver resection: a single center analy-
sis. World J Gastroenterol 16:2388–2395.
11. Rees JR, Blazeby JM, Fayers P, Friend EA, Welsh FK, John TG et al.
(2012) Patient-reported outcomes after hepatic resection of colorectal
cancer metastases. J Clin Oncol 30:1364–1370.
12. Langenhoff BS, Krabbe PF, Peerenboom L, Wobbes T, Ruers TJ.
(2006) Quality of life after surgical treatment of colorectal liver metasta-
ses. Br J Surg 93:1007–1014.
13. Banz VM, Inderbitzin D, Fankhauser R, Studer P, Candinas D. (2009)
Long-term quality of life after hepatic resection: health is not simply the
absence of disease. World J Surg 33:1473–1480.
14. Dasgupta D, Smith AB, Hamilton-Burke W, Prasad KR, Toogood GJ,
Velikova G et al. (2008) Quality of life after liver resection for hepatobil-
iary malignancies. Br J Surg 95:845–854.
15. Blazeby JM, Fayers P, Conroy T, Sezer O, Ramage J, Rees M et al.
(2009) Validation of the European Organization for Research and Treat-
ment of Cancer QLQ-LMC21 questionnaire for assessment of patient-
HPB 2015, 17, 839–845 ª 2015 International Hepato-Pancreato-Biliary Association
HPB 843
reported outcomes during treatment of colorectal liver metastases. Br J
Surg 96:291–298.
16. Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Koller M et al.
(2003) Development of an EORTC disease-specific quality of life ques-
tionnaire for use in patients with liver metastases from colorectal can-
cer. Eur J Cancer 39:1259–1263.
17. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Na-
gorney DM et al. (2004) Risk factors for early death due to recurrence
after liver resection for hepatocellular carcinoma: results of a multicen-
ter study. J Surg Oncol 85:36–41.
18. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al. (2006)
Chemotherapy regimen predicts steatohepatitis and an increase in 90-
day mortality after surgery for hepatic colorectal metastases. J Clin On-
col 24:2065–2072.
19. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S et al.
(2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients
undergoing major hepatectomy. J Am Coll Surg 204, 854–862. discus-
sion 62–4.
20. Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. (2009)
Survival after hepatic resection of colorectal cancer metastases: a
national experience. Cancer 115:752–759.
21. Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA et al.
(2011) Refining the definition of perioperative mortality following hepa-
tectomy using death within 90 days as the standard criterion. HPB
13:473–482.
22. Nishio H, Hidalgo E, Hamady ZZ, Ravindra KV, Kotru A, Dasgupta D
et al. (2005) Left hepatic trisectionectomy for hepatobiliary malignancy:
results and an appraisal of its current role. Ann Surg 242:267–275.
23. Gold JS, Are C, Kornprat P, Jarnagin WR, Gonen M, Fong Y et al.
(2008) Increased use of parenchymal-sparing surgery for bilateral liver
metastases from colorectal cancer is associated with improved mortal-
ity without change in oncologic outcome: trends in treatment over time
in 440 patients. Ann Surg 247:109–117.
24. Breitenstein S, DeOliveira ML, Raptis DA, Slankamenac K, Kam-
bakamba P, Nerl J et al. (2010) Novel and simple preoperative score
predicting complications after liver resection in noncirrhotic patients.
Ann Surg 252:726–734.
25. Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Mar-
tin RC 2nd et al. (2011). Importance of low preoperative platelet
count in selecting patients for resection of hepatocellular carcinoma:
a multi-institutional analysis. J Am Coll Surg 212:638–648; discussion
48–50.
26. Okamura Y, Takeda S, Fujii T, Sugimoto H, Nomoto S, Nakao A. (2011)
Prognostic significance of postoperative complications after hepatec-
tomy for hepatocellular carcinoma. J Surg Oncol 104:814–821.
27. Thelen A, Benckert C, Tautenhahn HM, Hau HM, Bartels M, Linnemann
J et al. (2013) Liver resection for hepatocellular carcinoma in patients
without cirrhosis. Br J Surg 100:130–137.
28. Dindo D, Demartines N, Clavien PA. (2004) Classification of surgical
complications: a new proposal with evaluation in a cohort of 6336
patients and results of a survey. Ann Surg 240:205–213.
29. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M,
Adam R et al. (2011) Posthepatectomy liver failure: a definition and
grading by the International Study Group of Liver Surgery (ISGLS). Sur-
gery 149:713–724.
30. Egger ME, Squires MH 3rd, Kooby DA, Maithel SK, Cho CS, Weber
SM et al. (2015) Risk stratification for readmission after major hepa-
tectomy: development of a readmission risk score. J Am Coll Surg
220:640–648.
31. Shah BC, Ullrich F, Smith L, Leiphrakpam P, Ly Q, Sasson A et al.
(2011) National trends in discharge disposition after hepatic resection
for malignancy. HPB 13:96–102.
32. Barbas AS, Turley RS, Mallipeddi MK, Lidsky ME, Reddy SK, White RR
et al. (2013) Examining reoperation and readmission after hepatic sur-
gery. J Am Coll Surg 216:915–923.
33. Correa-Gallego C, Gonen M, Fischer M, Grant F, Kemeny NE, Arslan-
Carlon V et al. (2013) Perioperative complications influence recurrence
and survival after resection of hepatic colorectal metastases. Ann Surg
Oncol 20:2477–2484.
34. Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Al-Ali H et al. (2013)
Up-front hepatic resection for metastatic colorectal cancer results in
favorable long-term survival. Ann Surg Oncol 20:295–304.
35. Heffernan H, Cella D, Webster K, Odom L, Martone M, Passik S et al.
(2002) Measuring health-related quality of life in patients with hepatobil-
iary cancers: the functional assessment of cancer therapy-hepatobiliary
questionnaire. J Clin Oncol 20:2229–2239.
36. Lim C, Dejong CH, Farges, O, e HSGftAdCH-BedT. (2015). Improving
the quality of liver resection: a systematic review and critical analysis of
the available prognostic models. HPB 17:209–221.
37. Dimick JB, Cowan JA Jr, Knol JA, Upchurch GR Jr. (2003) Hepatic
resection in the United States: indications, outcomes, and hospital pro-
cedural volumes from a nationally representative database. Arch Surg
138:185–191.
38. Yanaga K, Wakasugi K, Matsusaka T, Kume H. (2003) Hepatic resection
without mortality at a community hospital. Int Surg 88:87–91.
39. Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. (2004)
Follow-up of colorectal cancer patients after resection with curative
intent-the GILDA trial. Surg Oncol 13:119–124.
40. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D et al.
(2005) The “50-50 criteria” on postoperative day 5: an accurate predic-
tor of liver failure and death after hepatectomy. Ann Surg 242:824–828,
discussion 8–9.
41. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo
PC. (2006) Predictive indices of morbidity and mortality after liver resec-
tion. Ann Surg 243:373–379.
42. Jovine E, Biolchini F, Talarico F, Lerro FM, Mastrangelo L, Selleri S
et al. (2007) Major hepatectomy in patients with synchronous colorectal
liver metastases: whether or not a contraindication to simultaneous
colorectal and liver resection? Colorectal Dis 9:245–252.
43. Lancaster RT, Tanabe KK, Schifftner TL, Warshaw AL, Henderson WG,
Khuri SF et al. (2007) Liver resection in veterans affairs and selected
university medical centers: results of the patient safety in surgery study.
J Am Coll Surg 204:1242–1251.
44. Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD
et al. (2008) Operative mortality after hepatic resection: are literature-
based rates broadly applicable? J Gastrointest Surg 12:842–851.
45. McKay A, You I, Bigam D, Lafreniere R, Sutherland F, Ghali W et al.
(2008) Impact of surgeon training on outcomes after resective hepatic
surgery. Ann Surg Oncol 15:1348–1355.
46. Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J et al.
(2009) Predicting poor outcome following hepatectomy: analysis of
2313 hepatectomies in the NSQIP database. HPB 11:510–515.
47. Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ et al.
(2009) Three hundred and one consecutive extended right hepatecto-
HPB 2015, 17, 839–845 ª 2015 International Hepato-Pancreato-Biliary Association
844 HPB
mies: evaluation of outcome based on systematic liver volumetry. Ann
Surg 250:540–548.
48. Lai IR, Yeh CC, Yu SC. (2009) Laparoscopic liver resection for hepato-
cellular carcinoma: intermediate follow-up results. Hepatogastroenterol-
ogy 56:1082–1085.
49. Nathan H, Schulick RD, Choti MA, Pawlik TM. (2009) Predictors of sur-
vival after resection of early hepatocellular carcinoma. Ann Surg
249:799–805.
50. Brooke BS, Meguid RA, Makary MA, Perler BA, Pronovost PJ, Pawlik
TM. (2010) Improving surgical outcomes through adoption of evidence-
based process measures: intervention specific or associated with over-
all hospital quality? Surgery 147:481–490.
51. Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Engle-
sbe MJ et al. (2010) Body mass index and adverse perioperative out-
comes following hepatic resection. J Gastrointest Surg 14:1285–1291.
52. Nanashima A, Tobinaga S, Abo T, Nonaka T, Takeshita H, Hidaka S
et al. (2010) Reducing the incidence of post-hepatectomy hepatic com-
plications by preoperatively applying parameters predictive of liver func-
tion. J Hepatobiliary Pancreat Sci 17:871–878.
53. Nathan H, de Jong MC, Pulitano C, Ribero, D, Strub J, Mentha G et al.
(2010) Conditional survival after surgical resection of colorectal liver
metastasis: an international multi-institutional analysis of 949 patients. J
Am Coll Surg 210:755–764, 64–6.
54. Tranchart H, Di Giuro G, Lainas P, Roudie J, Agostini H, Franco D et al.
(2010) Laparoscopic resection for hepatocellular carcinoma: a matched-
pair comparative study. Surg Endosc 24:1170–1176.
55. Hu BS, Chen K, Tan HM, Ding XM, Tan JW. (2011) Comparison of lapa-
roscopic vs open liver lobectomy (segmentectomy) for hepatocellular
carcinoma. World J Gastroenterol 17:4725–4728.
56. Okabayashi T, Iyoki M, Sugimoto T, Kobayashi M, Hanazaki K. (2011)
Oral supplementation with carbohydrate- and branched-chain amino
acid-enriched nutrients improves postoperative quality of life in patients
undergoing hepatic resection. Amino Acids 40:1213–1220.
57. Strasberg SM, Hall BL. (2011) Postoperative morbidity index: a quanti-
tative measure of severity of postoperative complications. J Am Coll
Surg 213:616–626.
58. Bhayani NH, Hyder O, Frederick W, Schulick RD, Wolgang CL, Hirose
K et al. (2012) Effect of metabolic syndrome on perioperative outcomes
after liver surgery: a National Surgical Quality Improvement Program
(NSQIP) analysis. Surgery 152:218–226.
59. Brooke BS, Dominici F, Pronovost PJ, Makary MA, Schneider E, Pawlik
TM. (2012) Variations in surgical outcomes associated with hospital
compliance with safety practices. Surgery 151:651–659.
60. Chen X, Zhai J, Cai X, Zhang Y, Wei L, Shi L et al. (2012) Severity of
portal hypertension and prediction of postoperative liver failure after
liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg
99:1701–1710.
61. Farges, O, Goutte N, Bendersky N, Falissard B. (2012) Incidence and
risks of liver resection: an all-inclusive French nationwide study. Ann
Surg 256:697–704, discussion -5.
62. Lee KF, Cheung YS, Wong J, Chong CC, Wong JS, Lai PB. (2012) Ran-
domized clinical trial of open hepatectomy with or without intermittent
Pringle manoeuvre. Br J Surg 99:1203–1209.
63. Saunders JK, Rosman AS, Neihaus D, Gouge TH, Melis M. (2012)
Safety of hepatic resections in obese veterans. Arch Surg 147:331–
337.
64. Toro A, Pulvirenti E, Palermo F, Di Carlo I. (2012) Health-related quality
of life in patients with hepatocellular carcinoma after hepatic resection,
transcatheter arterial chemoembolization, radiofrequency ablation or no
treatment. Surg Oncol 21:e23–e30.
65. Turley RS, Reddy SK, Shortell CK, Clary BM, Scarborough JE. (2012)
Venous thromboembolism after hepatic resection: analysis of 5,706
patients. J Gastrointest Surg 16:1705–1714.
66. Worni M, Mantyh CR, Akushevich I, Pietrobon R, Clary BM. (2012) Is
there a role for simultaneous hepatic and colorectal resections? A con-
temporary view from NSQIP. J Gastrointest Surg 16:2074–2085.
67. Yasunaga H, Hashimoto H, Horiguchi H, Miyata H, Matsuda S. (2012)
Variation in cancer surgical outcomes associated with physician and
nurse staffing: a retrospective observational study using the Japanese
Diagnosis Procedure Combination Database. BMC health Serv Res
12:129.
68. Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ
et al. (2013) Improved long-term survival after major resection for hepa-
tocellular carcinoma: a multicenter analysis based on a new definition
of major hepatectomy. J Gastrointest Surg 17:66–77; discussion p.
69. Sg DLF, Bennett KM, Scarborough JE. (2013) Functional status deter-
mines postoperative outcomes in elderly patients undergoing hepatic
resections. J Surg Oncol 107:865–870.
70. Loehrer AP, House MG, Nakeeb A, Kilbane EM, Pitt HA. (2013) Cholan-
giocarcinoma: are North American surgical outcomes optimal? J Am
Coll Surg 216:192–200.
71. Moreno Elola-Olaso A, Davenport DL, Hundley JC, Daily MF, Gedaly R.
(2012) Predictors of surgical site infection after liver resection: a multi-
centre analysis using National Surgical Quality Improvement Program
data. HPB 14:136–141.
72. Ribeiro HS, Costa WL Jr, Diniz AL, Godoy AL, Herman P, Coudry RA
et al. (2013) Extended preoperative chemotherapy, extent of liver
resection and blood transfusion are predictive factors of liver failure
following resection of colorectal liver metastasis. Eur J Surg Oncol
39:380–385.
73. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH et al.
(2013). Optimal future liver remnant in patients treated with extensive
preoperative chemotherapy for colorectal liver metastases. Ann Surg
Oncol 20:2493–2500.
HPB 2015, 17, 839–845 ª 2015 International Hepato-Pancreato-Biliary Association
HPB 845
